Kingstone Capital Partners Texas, LLC Acadia Pharmaceuticals Inc Call Options Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
355Shares Held
163MCall Options Held
1.77MPut Options Held
307K-
Baker Bros. Advisors LP New York, NY42.9MShares$925 Million8.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$328 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$260 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.54MShares$184 Million2.32% of portfolio
-
State Street Corp Boston, MA6.99MShares$151 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.49B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...